5.13 Brevetto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.358
EU - Europa 7.232
AS - Asia 5.249
SA - Sud America 539
Continente sconosciuto - Info sul continente non disponibili 379
AF - Africa 100
OC - Oceania 2
Totale 22.859
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.229
IT - Italia 2.208
CN - Cina 1.449
RU - Federazione Russa 1.318
SG - Singapore 1.215
SE - Svezia 1.118
IE - Irlanda 754
KR - Corea 675
TR - Turchia 533
DE - Germania 473
BR - Brasile 407
UA - Ucraina 385
VN - Vietnam 373
GB - Regno Unito 308
HK - Hong Kong 301
BD - Bangladesh 293
FR - Francia 182
FI - Finlandia 159
IN - India 128
CH - Svizzera 117
CA - Canada 62
AT - Austria 60
IQ - Iraq 46
PK - Pakistan 37
AR - Argentina 35
MX - Messico 35
NL - Olanda 33
ZA - Sudafrica 31
SA - Arabia Saudita 30
ID - Indonesia 28
VE - Venezuela 25
AL - Albania 23
CO - Colombia 22
UZ - Uzbekistan 22
ES - Italia 21
EU - Europa 21
PL - Polonia 21
AE - Emirati Arabi Uniti 20
BE - Belgio 19
JP - Giappone 18
EC - Ecuador 17
MY - Malesia 17
TN - Tunisia 15
MA - Marocco 14
PH - Filippine 12
LT - Lituania 10
CL - Cile 9
EG - Egitto 9
PE - Perù 9
DZ - Algeria 7
ET - Etiopia 7
IL - Israele 7
TT - Trinidad e Tobago 7
JO - Giordania 6
PY - Paraguay 6
AZ - Azerbaigian 5
CR - Costa Rica 5
UY - Uruguay 5
CZ - Repubblica Ceca 4
JM - Giamaica 4
NP - Nepal 4
BG - Bulgaria 3
BO - Bolivia 3
KG - Kirghizistan 3
SN - Senegal 3
TH - Thailandia 3
AM - Armenia 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
GR - Grecia 2
GT - Guatemala 2
HU - Ungheria 2
IR - Iran 2
KE - Kenya 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
LY - Libia 2
ME - Montenegro 2
NI - Nicaragua 2
OM - Oman 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TW - Taiwan 2
AG - Antigua e Barbuda 1
AU - Australia 1
BH - Bahrain 1
BJ - Benin 1
BS - Bahamas 1
BW - Botswana 1
CI - Costa d'Avorio 1
CY - Cipro 1
DJ - Gibuti 1
DM - Dominica 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
Totale 22.481
Salva come PNG Salva come JPEG
Città #
Pisa 992
Council Bluffs 938
Ashburn 877
Jacksonville 857
Dublin 751
Chandler 747
Dallas 725
San Jose 717
Seoul 673
Singapore 472
Boardman 461
Izmir 396
Wilmington 364
Ann Arbor 325
Moscow 313
Beijing 308
Hong Kong 286
Hefei 249
Milan 236
Düsseldorf 182
Boston 178
Millbury 175
Dong Ket 144
Clifton 130
Los Angeles 128
Kent 115
San Mateo 115
Istanbul 109
Lauterbourg 105
Mestre 104
New York 101
The Dalles 99
Bern 92
Seattle 88
Woodbridge 86
Dearborn 78
Bremen 76
Ho Chi Minh City 75
Rome 73
Lawrence 71
Santa Clara 67
Ogden 65
Buffalo 60
North Bergen 60
Scuola 60
Florence 59
Brescia 58
Hanoi 55
Princeton 54
Vienna 54
Chicago 49
Guangzhou 43
Saint Petersburg 43
San Giuliano Terme 39
Munich 38
São Paulo 33
Helsinki 32
Orem 31
Shanghai 31
Chennai 28
Phoenix 28
Miano 26
Toronto 26
London 24
Figino 23
Brooklyn 22
Wuhan 22
Nanjing 21
Padova 21
Manchester 19
Tashkent 19
Warsaw 19
Washington 19
Johannesburg 18
Kunming 18
Montreal 18
Zurich 18
Atlanta 16
Baghdad 16
Brussels 16
Houston 16
Naples 15
Tokyo 15
Andover 14
Frankfurt am Main 14
Jiaxing 14
Turin 14
Da Nang 13
Jinan 13
Mexico City 13
Norwalk 13
Turku 13
Bientina 12
Lahore 12
Rio de Janeiro 12
San Francisco 12
Yiwu 12
Amsterdam 11
Calci 11
Cambridge 11
Totale 14.639
Salva come PNG Salva come JPEG
Nome #
Liquid motion control device for Lab-on-a-Chip (LOC) system of e.g. food analysis apparatus, has control unit with acoustic resonator that reflects surface acoustic wave (SAW) when quantity of liquid is present within acoustic resonator 328
METHOD TO ANIMATE ON A COMPUTER SCREEN A VIRTUAL PEN WHICH WRITES AND DRAWS 323
METODO PER ANIMARE SULLO SCHERMO DI UN COMPUTER UNA PENNA VIRTUALE CHE SCRIVE E DISEGNA 319
METHOD TO ANIMATE ON A COMPUTER SCREEN A VIRTUAL PEN WHICH WRITES AND DRAWS 307
VECTOR FOR THE RELEASE OF AN ACTIVE AGENT WHICH IS PHOTOCLEAVABLE BY IRRADIATION IN THE VISIBLE 297
Bucket brigade address decoding architecture for classical and quantum random access memories 294
Composti particolarmente catalizzatori di poliuretani 288
Dispositivo automatizzato per la riabilitazione motoria e per la valutazione della funzionalità degli arti anteriori in modelli animali 281
METHOD TO SYNCHRONIZE AUDIO AND GRAPHICS IN A MULTIMEDIA PRESENTATION 278
COMPOSIZIONI IN GRADO DI PREVENIRE EVENTI NEURODEGENERATIVI E METODO PER SAGGIARNE L'ATTIVITA' 275
Determinazione dell'organizzazione supramolecolare di molecole incapsulate tramite analisi del tempo di vita della luminescenza 271
Method and device for measuring position and mass 270
Superfici funzionali con morfologia controllata sulla scala nanometrica atte a modulare l’adesione, vitalità e proliferazione di cellule 261
NACYLUREA COMPOUNDS FOR PREPARING POLYURETHANES 254
ANIMALI TRANSGENICI NON UMANI ANTI-NGF 246
MUTEINS OF HNGF, THERAPEUTIC USES AND PHARMACEUTICAL COMPOSITIONS 245
METHOD TO SYNCHRONIZE AUDIO AND GRAPHICS IN A MULTIMEDIA PRESENTATION 244
Laser circolari a semiconduttore con reticoli per emissione verticale 231
Metodo non invasivo per misurare il contenuto idrico assoluto di una foglia 223
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 213
Nanoresonator structure used as nanosensor for e.g. medical application, comprises conductive material layers and dielectric layer, and is represented by specific circuit with resonant frequency determined by geometrical dimensions 210
Use of an anti-NGF IgG4 isotype antibody for treating and/or preventing chronic pain 204
VECTOR FOR THE RELEASE OF AN ACTIVE AGENT WHICH IS PHOTOCLEAVABLE BY IRRADIATION IN THE VISIBLE 196
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 195
NOVEL ANALGESIC TREATMENT WITH PROLONGED EFFECT 191
Method for the humanization of antibodies and humanized antibodies thereby obtained 190
Method for Ensuring privacy while querying a database by using quantum superpositions and multiple responses 189
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 187
INTRACELLULAR ANTIBODIES 185
COMPOSITIONS ABLE TO PREVENT NEURODEGENERATIVE PROCESSES AND METHODS OF ASSAYING THE SAME 185
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 183
Method for the humanization of antibodies and humanized antibodies thereby obtained 182
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT. 180
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 180
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 179
Method for the humanization of antibodies and humanized antibodies thereby obtained. 179
Method for the potentiation of opioid analgesics effects on pain 178
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 176
ANIMALI TRANSGENICI NON UMANI ESPRIMENTI ANTICORPI ANTI-NGF. 176
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 172
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 169
Selection of intracellular immunoglobulins 169
Method of identifying a consensus sequence for intracellular antibodies 169
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 168
Method for the humanization of antibodies and humanized antibodies thereby obtained. 168
Novel analgesic treatment with prolonged effect 168
Method for the potentiation of opioid analgesics effects on pain 168
METODO PER IDENTIFICARE UN INIBITORE SELETTIVO DEL PRONGF E INIBITORI SELEZIONATI CON ESSO 168
Intracellular selection 168
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 167
Non human transgenic animal as a model of neurodegenerative diseases and for the early diagnosis thereof 167
Intracellular selection 166
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 165
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 165
Selection of intracellular immunoglobulins 165
Novel analgesic treatment with prolonged effect 165
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 164
Humanized anti-NGF antibodies 164
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TRKA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 164
Intracellular selection 163
Humanized anti-NGF antibodies 163
INTRACELLULAR ANTIBODIES 163
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 162
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 161
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 161
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 160
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 159
Method for the humanization of antibodies and humanized antibodies thereby obtained 159
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 159
NGF AND TrkA RECEPTOR BINDING INHIBITING MOLECULES AS PROLONGED ANALGESICS 158
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 158
Selection of intracellular immunoglobulins 158
Selection of intracellular immunoglobulins 158
SEQUENZE CONSENSO PER ANTICORPI INTRACELLULARI E LORO USO 157
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 157
Method for the humanization of antibodies and humanized antibodies thereby obtained. 157
TRANSGENIC MICE FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 157
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 156
Method for the humanization of antibodies and humanized antibodies thereby obtained. 156
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 155
Non-human transgenic animals for the study of neurodegenerative syndromes 154
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 154
Selection of intracellular immunoglobulins 154
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 154
Humanized anti-NGF antibodies 153
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 153
Method for the humanization of antibodies and humanized antibodies thereby obtained 152
Molecules that are able to inhibit the binding between NGF and the Trka receptor as analgesics with prolonged effect 152
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 152
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 152
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 151
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 151
null 150
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TRKA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 150
Novel analgesic treatment with prolonged effect 150
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 150
Molecules that are able to inhibit the binding between NGF and the TrkA receptor as analgesics with prolonged effect 149
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 149
Humanized anti-NGF antibodies 149
Method for the potentiation of opioid analgesics effects on pain 148
Totale 18.696
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022794 0 0 22 121 15 5 10 69 50 58 19 425
2022/20233.491 239 136 136 218 159 378 0 970 1.112 22 38 83
2023/20241.158 208 48 93 31 53 120 18 116 195 22 18 236
2024/20253.201 92 34 174 168 468 14 39 187 643 147 594 641
2025/20267.821 541 653 971 683 298 315 1.090 456 963 593 564 694
2026/20271.533 1.252 281 0 0 0 0 0 0 0 0 0 0
Totale 22.859